.jpg)
The Invisible Cancer - Bringing Visibility to Neuroendocrine Cancer
The Invisible Cancer Podcast raises awareness of neuroendocrine cancer, a cancer most people have never heard of, and this lack of awareness can affect diagnosis, treatment, and care. Through real-life stories, expert insights, and practical advice, we explore the challenges patients face, from initial diagnosis to management, including the impact on mental health and ongoing follow-up.
Hosted by Lisa Walker and produced by Neuroendocrine Cancer UK, this podcast shines a light on neuroendocrine and other often-overlooked cancers, offering information, support, and connection to anyone affected.
The Invisible Cancer - Bringing Visibility to Neuroendocrine Cancer
Neuroendocrine Cancer Research: Humanising Clinical Trials with Ancora.ai
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this week's podcast episode, we feature Ancora.ai, a company connecting cancer patients with clinical trials and empowering them to understand ongoing trial options.
Ancora.ai maintains a research database of all ongoing cancer trials, including neuroendocrine cancer, making it easier for patients to find personalised trial options. The podcast with CEO and founder, Danielle Ralic, explores the challenges of finding relevant clinical trials and how Ancora.ai helps overcome them. Listeners will learn about the company's serendipitous origin and the opportunities it offers for patients to understand and discuss clinical trials with their medical teams. Ancora.ai is easy to use, fast, and free, making it a valuable resource for cancer patients seeking innovative treatments.
Useful links:
